Patent · US Expired

Dihydrospirorenone as an antiandrogen

US5569652A · kind A · utility

63Cited by

6References

27Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Sybille Beier · Berlin, DE
Walter Elger · Berlin, DE
Yukishige Nishino · Berlin, DE
Rudolf Wiechert · Berlin, DE

Key dates

Filing date	Dec 7, 1993
Grant date	Oct 29, 1996
Priority date	—
Expiry date	Dec 7, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/585
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Dihydrospirorenone, ##STR1## preferably together with an estrogen, can be used for the production of a pharmaceutical agent suitable for treatment of hormonal irregularities during premenopause (menstruation stabilization), for hormonal substitution therapy during menopause, for treatment of androgen-induced disorders and/or for contraception.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.